What is Regenerative Medicine?
It is more rational, practical and medically preferable to help nature regrow or regenerate the superior biological structures and organs with which we were born. Regenerative Medicine is a discipline that uses nature’s chemistry and biology through injectables like Wharton’s Jelly to help the body repair and enhance the functionality of structures like joints, rather than to patch, replace, or mask the pain with drugs.
Regenerative Cell Therapy is an outpatient, non-surgical procedure used by advanced medical offices to accelerate your body’s healing process. The process involves a simple injection.
The procedure is very comfortable and the whole process can be completed in less than an hour in most cases. Best of all, there is no downtime and, in some cases, immediate “up time” within just a few weeks. Every response varies by individual and there are no guarantees.
Ethically Derived from Healthy Donors
Our Allograft products are obtained from Labs that are under the American Association of Tissue Banks and FDA Guidance. These tissues are acquired from living, healthy donors after full-term pregnancy and a scheduled Caesarean section (C-section). Donors are healthy women who are thoroughly screened for communicable diseases. The Labs do a careful medical and social history collected in advance to ensure that mothers meet all eligibility requirements.
Reduced risk of Immune Reaction
Studies have described the placental tissues as “immune privileged” because they rarely evoke an immune response in the human body. This reduces the risk of an adverse immune reaction. Amniotic tissue also has reported anti-inflammatory, anti-bacterial, and anti-fibrotic properties.
More About Wharton’s Jelly Umbilical Cord Tissue
The umbilical cord is the lifeline that attaches the placenta to the fetus and is physiologically and genetically part of the fetus.
Wharton’s Jelly is a minimally manipulated derived human tissue allograft. It is a gelatinous substance within the umbilical cord, largely made up of mucopolysaccharides (hyaluronic acid and chondroitin sulfate). It also contains some fibroblasts and macrophages.
Wharton’s Jelly is rich in mesenchymal stem cells, structural proteins, cytokines, chemokine, and numerous growth factors. This tissue is a rich source of various biologically active elements involved in tissue regeneration with reported anti-inflammatory, anti-bacterial, epithelialization, and anti-fibrotic properties, making it an attractive biomaterial for homologous use in damaged joint procedures.
Advantages of Using Wharton’s Jelly
Wharton’s Jelly products are less invasive than using adipose tissue extraction and bone marrow aspiration resulting in less time-consuming procedures, and more importantly less pain.
Wharton’s Jelly does not use any material obtained directly from an embryo or fetus.
Wharton’s Jelly is regulated by the FDA as a human cell, tissue or cellular tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.
Stem Cell Research
Therapeutic potential of stem cell based treatment in Regenerative Medicine
Mesenchymal Stem Cells: Environmentally Responsive Therapeutics for Regenerative Medicine
Mesenchymal Stem Cells In The Treatment Of Traumatic Articular Cartilage Defects: A Comprehensive Review
Osteoarthritis is a painful and cruel disease that effects musculoskeletal structure all over the body, including the hands, knees, hips, spine and feet. It can be difficult to diagnose, and the primary symptom is obesity. Traditional treatments like cortisone injections are like to be replaced by regenerative therapies, because of the chronic nature of the disease.
Intra-articular Injection Of Mesenchymal Stem Cells For The Treatment Of Osteoarthritis Of The Knee: A Proof-of-concept Clinical Trial.
Safety And Complications Reporting On The Re-implantation Of Culture-expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique.
Articular Cartilage Regeneration With Autologous Peripheral Blood Stem Cells Versus Hyaluronic Acid: A Randomized Controlled Trial. View Article
Increased Knee Cartilage Volume In Degenerative Joint Disease Using Percutaneously Implanted, Autologous Mesenchymal Stem Cells.
Signup up for a consultation with one of our regenerative medicine experts